Short Interest in PharmaCielo Ltd. (OTCMKTS:PCLOF) Decreases By 39.2%

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totaling 52,246 shares, a decrease of 39.2% from the April 15th total of 85,990 shares. Based on an average trading volume of 215,929 shares, the days-to-cover ratio is currently 0.2 days.

PharmaCielo Trading Down 9.0%

Shares of PCLOF stock traded down $0.01 during mid-day trading on Friday, hitting $0.06. 64,186 shares of the stock were exchanged, compared to its average volume of 71,111. The firm has a fifty day moving average of $0.04 and a 200 day moving average of $0.04. PharmaCielo has a 52-week low of $0.00 and a 52-week high of $0.12.

About PharmaCielo

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.